SHPl Acquires The Med-Design Corporation
TM Capital advised Specialized Health Products International, Inc. (OTC: SHPI) in its acquisition of The Med-Design Corporation (NASDAQ: MEDC)
TM Capital advised Specialized Health Products International, Inc. (OTC: SHPI) in its acquisition of The Med-Design Corporation (NASDAQ: MEDC)
TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital
TM Capital advised Everest Biomedical Instruments Co Inc. in its sale to Stryker Corporation (NYSE:SYK), a world leader in the development, manufacture and marketing of orthopedic products and medical specialties
TM Capital advised Immucor, Inc. (NASDAQ) on its $117 million acquisition of BioArray Solutions Ltd.
TM Capital assisted The MedTech Group in completing a recapitalization with KRG Capital Partners to accelerate growth and provide shareholder liquidity
TM Capital advised Dinex Holdings, a provider of specialty foodservice products to healthcare markets, in its $95 million sale to Carlisle Companies (NYSE), a $2 billion diversified global manufacturer
TM Capital advised Freedom Innovations and ACT Medical in a leveraged recapitalization led by Telegraph Hill Partners and Tailwind Capital Group whereby they acquired a 73% stake in the combined company
TM Capital advised Chestnut Medical Technologies in its sale to ev3 Inc. (NASDAQ: EVVV) for $150 million in cash and stock
TM Capital advised CryoCath Technologies (TSX: CYT) in its sale to Medtronic, Inc. (NYSE: MDT) for a C$425mm enterprise value in an all-cash takeover bid
TM Capital advised TechHealth in completing a dividend recapitalization transaction